1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Immunonutrition: new trials by email Literature Review of Immunonutrition trials Research Report on Immunonutrition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma Radiotherapy, Programmed Cell Death Protein 1 Inhibitor, Immunonutrition support - Locally Advanced Esophageal Squamous Cell Carcinoma, Sintilimab | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 57 | 2024-03-14 | 2026-10-07 |
Immune Checkpoint Inhibitors (1) · Radiotherapy (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
China (1)